SIRT7 and breast carcinoma: Additionally, SIRT7 interacts with LAP2α in breast cancer, and inhibition of the SIRT7/LAP2α axis represents a potential therapeutic strategy for preventing breast cancer metastasis (Huo et al., 2023).